Alterations in the relative abundance of Faecalibacterium prausnitzii correlate with changes in fecal calprotectin in patients with ileal Crohn’s disease: a longitudinal study-Reference-Cited by-同舟云学术

Alterations in the relative abundance of Faecalibacterium prausnitzii correlate with changes in fecal calprotectin in patients with ileal Crohn’s disease: a longitudinal study

Published:2019-05-04 Issue:5 Volume:54 Page:577-585
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Björkqvist Olle¹^ORCID,Repsilber Dirk¹,Seifert Maike²,Brislawn Colin³,Jansson Janet³,Engstrand Lars²,Rangel Ignacio¹,Halfvarson Jonas⁴

Affiliation:

1. School of Medical Sciences, Örebro University, Örebro, Sweden;

2. Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden;

3. Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, WA, USA;

4. Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

Funder

Swedish Foundation For Strategic Research

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://tandfonline.com/doi/pdf/10.1080/00365521.2019.1599417

Reference42 articles.

1. Dynamics of the human gut microbiome in inflammatory bowel disease

2. The Treatment-Naive Microbiome in New-Onset Crohn’s Disease

3. Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence

4. Role of the faecal stream in the maintenance of Crohn's colitis.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Faecalibacterium duncaniae A2‐165 growth is strongly promoted by yeast extract and vitamin B5 in cGMP medium;Microbial Biotechnology;2023-11-29

2. Modifying the Microbiome as a Potential Mechanism of Photobiomodulation: A Case Report;Photobiomodulation, Photomedicine, and Laser Surgery;2021-12-28

3. Gut Microbiome-Mediated Alteration of Immunity, Inflammation, and Metabolism Involved in the Regulation of Non-alcoholic Fatty Liver Disease;Frontiers in Microbiology;2021-11-02

4. Drug Targeting of Inflammatory Bowel Diseases by Biomolecules;Nanomaterials;2021-08-10

5. MAP, Johne’s disease and the microbiome; current knowledge and future considerations;Animal Microbiome;2021-05-07